title: Perioperative management in thoracic surgery.
abstract: The quality of perioperative treatment for patients undergoing thoracic surgery is of the utmost importance for postoperative morbidity and mortality. Hence, it was the purpose of this study to examine various aspects of our own procedure. The clinical course following 812 successive thoracotomies in 792 patients over a period of 3 years was documented and analysed. The overall complication rate was found to be 19.7%, with a mortality of 3.8% over a 30-day period. Secretostasis, atelectasis and pneumonia were the most common complications. Owing to the predeposition of autologous blood, the percentage of patients requiring allogeneic blood transfusion was reduced from 27% to 9%. There was no evidence suggesting an increase in the complication rate or a longer stay in hospital. Perioperative antibiotic prophylaxis has reduced postoperative wound infection significantly. Similar reductions in the FEV1 are recorded following thoracic surgery, irrespective of the amount of lung tissue resected. This observation indicates that the remaining lung tissue is severely compromised throughout the postoperative period and that the surgical trauma alone is a major factor influencing postoperative pulmonary function for at least 2 weeks.
authors.affiliation: Chirurgische Klinik, Klinikum Innenstadt, Ludwig-Maximilians-Universität München, Germany.
authors.forename: K
authors.initials: K
authors.lastname: Hallfeldt
authors.forename: G
authors.initials: G
authors.lastname: Dornschneider
authors.forename: C
authors.initials: C
authors.lastname: Richter
authors.forename: O
authors.initials: O
authors.lastname: Thetter
authors.forename: L
authors.initials: L
authors.lastname: Schweiberer
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D001804:Blood Transfusion, Autologous; D005260:Female; D005500:Follow-Up Studies; D005541:Forced Expiratory Volume / Q000502:physiology; D006801:Humans; D008171:Lung Diseases / Q000401:mortality / Q000601:surgery; D008175:Lung Neoplasms / Q000401:mortality / Q000601:surgery; D008297:Male; D008875:Middle Aged; D011182:Postoperative Care / Q000379:methods*; D011183:Postoperative Complications / Q000401:mortality / Q000628:therapy*; D011292:Premedication; D011785:Quality Assurance, Health Care; D013530:Surgical Wound Infection / Q000401:mortality / Q000628:therapy; D015996:Survival Rate; D013896:Thoracic Diseases / Q000401:mortality / Q000601:surgery*; D013908:Thoracotomy
chemical_list: D000900:Anti-Bacterial Agents